First Time Loading...

Simulations Plus Inc
NASDAQ:SLP

Watchlist Manager
Simulations Plus Inc Logo
Simulations Plus Inc
NASDAQ:SLP
Watchlist
Price: 45.25 USD 1.23%
Updated: Apr 18, 2024

Intrinsic Value

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. [ Read More ]

The intrinsic value of one SLP stock under the Base Case scenario is 16.08 USD. Compared to the current market price of 45.25 USD, Simulations Plus Inc is Overvalued by 64%.

Key Points:
SLP Intrinsic Value
Base Case
16.08 USD
Overvaluation 64%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Simulations Plus Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SLP stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Simulations Plus Inc

Provide an overview of the primary business activities
of Simulations Plus Inc.

What unique competitive advantages
does Simulations Plus Inc hold over its rivals?

What risks and challenges
does Simulations Plus Inc face in the near future?

Has there been any significant insider trading activity
in Simulations Plus Inc recently?

Summarize the latest earnings call
of Simulations Plus Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Simulations Plus Inc.

Provide P/S
for Simulations Plus Inc.

Provide P/E
for Simulations Plus Inc.

Provide P/OCF
for Simulations Plus Inc.

Provide P/FCFE
for Simulations Plus Inc.

Provide P/B
for Simulations Plus Inc.

Provide EV/S
for Simulations Plus Inc.

Provide EV/GP
for Simulations Plus Inc.

Provide EV/EBITDA
for Simulations Plus Inc.

Provide EV/EBIT
for Simulations Plus Inc.

Provide EV/OCF
for Simulations Plus Inc.

Provide EV/FCFF
for Simulations Plus Inc.

Provide EV/IC
for Simulations Plus Inc.

Show me price targets
for Simulations Plus Inc made by professional analysts.

What are the Revenue projections
for Simulations Plus Inc?

How accurate were the past Revenue estimates
for Simulations Plus Inc?

What are the Net Income projections
for Simulations Plus Inc?

How accurate were the past Net Income estimates
for Simulations Plus Inc?

What are the EPS projections
for Simulations Plus Inc?

How accurate were the past EPS estimates
for Simulations Plus Inc?

What are the EBIT projections
for Simulations Plus Inc?

How accurate were the past EBIT estimates
for Simulations Plus Inc?

Compare the revenue forecasts
for Simulations Plus Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Simulations Plus Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Simulations Plus Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Simulations Plus Inc compared to its peers.

Compare the P/E ratios
of Simulations Plus Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Simulations Plus Inc with its peers.

Analyze the financial leverage
of Simulations Plus Inc compared to its main competitors.

Show all profitability ratios
for Simulations Plus Inc.

Provide ROE
for Simulations Plus Inc.

Provide ROA
for Simulations Plus Inc.

Provide ROIC
for Simulations Plus Inc.

Provide ROCE
for Simulations Plus Inc.

Provide Gross Margin
for Simulations Plus Inc.

Provide Operating Margin
for Simulations Plus Inc.

Provide Net Margin
for Simulations Plus Inc.

Provide FCF Margin
for Simulations Plus Inc.

Show all solvency ratios
for Simulations Plus Inc.

Provide D/E Ratio
for Simulations Plus Inc.

Provide D/A Ratio
for Simulations Plus Inc.

Provide Interest Coverage Ratio
for Simulations Plus Inc.

Provide Altman Z-Score Ratio
for Simulations Plus Inc.

Provide Quick Ratio
for Simulations Plus Inc.

Provide Current Ratio
for Simulations Plus Inc.

Provide Cash Ratio
for Simulations Plus Inc.

What is the historical Revenue growth
over the last 5 years for Simulations Plus Inc?

What is the historical Net Income growth
over the last 5 years for Simulations Plus Inc?

What is the current Free Cash Flow
of Simulations Plus Inc?

Financials

Balance Sheet Decomposition
Simulations Plus Inc

Current Assets 128m
Cash & Short-Term Investments 108.5m
Receivables 15.7m
Other Current Assets 3.7m
Non-Current Assets 66m
Long-Term Investments 9m
PP&E 1.9m
Intangibles 52.2m
Other Non-Current Assets 2.8m
Current Liabilities 14.5m
Accounts Payable 360k
Accrued Liabilities 6.6m
Other Current Liabilities 7.6m
Non-Current Liabilities 2.4m
Other Non-Current Liabilities 2.4m
Efficiency

Earnings Waterfall
Simulations Plus Inc

Revenue
64.7m USD
Cost of Revenue
-16.1m USD
Gross Profit
48.6m USD
Operating Expenses
-39.4m USD
Operating Income
9.2m USD
Other Expenses
1.3m USD
Net Income
10.5m USD

Free Cash Flow Analysis
Simulations Plus Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

SLP Profitability Score
Profitability Due Diligence

Simulations Plus Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive 3-Year Average ROIC
Positive Operating Income
61/100
Profitability
Score

Simulations Plus Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

SLP Solvency Score
Solvency Due Diligence

Simulations Plus Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Simulations Plus Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SLP Price Targets Summary
Simulations Plus Inc

Wall Street analysts forecast SLP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SLP is 54.74 USD with a low forecast of 51.51 USD and a high forecast of 57.75 USD.

Lowest
Price Target
51.51 USD
14% Upside
Average
Price Target
54.74 USD
21% Upside
Highest
Price Target
57.75 USD
28% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SLP Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SLP Price
Simulations Plus Inc

1M 1M
+8%
6M 6M
+15%
1Y 1Y
+7%
3Y 3Y
-27%
5Y 5Y
+107%
10Y 10Y
+749%
Annual Price Range
45.25
52w Low
33.3
52w High
51.51
Price Metrics
Average Annual Return 33.51%
Standard Deviation of Annual Returns 91.27%
Max Drawdown -62%
Shares Statistics
Market Capitalization 904.3m USD
Shares Outstanding 20 279 000
Percentage of Shares Shorted 10.78%

SLP Return Decomposition
Main factors of price return

What is price return decomposition?

SLP News

Other Videos

Company Profile

Simulations Plus Inc Logo
Simulations Plus Inc

Country

United States of America

Industry

Health Care

Market Cap

904.3m USD

Dividend Yield

0.52%

Description

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 135 full-time employees. The company provides prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support of product approval. The company offers 11 software products for pharmaceutical research and development, which includes GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ADMET Predictor, MedChem Designer, MedChem Studio, PKPlus, KIWI and Monolix Suite of products through Lixoft. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research. Cognigen Corporation, DILIsym Services, Inc. and Lixoft are its subsidiaries.

Contact

CALIFORNIA
Lancaster
42505 10th St W
+16617237723.0
https://www.simulations-plus.com/

IPO

1997-06-18

Employees

135

Officers

Co-Founder & Chairman
Dr. Walter S. Woltosz M.A.S., M.S.
Chief Executive Officer
Mr. Shawn M. O'Connor
COO, CFO & Secretary
Mr. William Frederick
President of PBPK & Cheminformatics Solutions
Mr. John Anthony DiBella M.S.
President of Quantitative Systems Pharmacology Solutions
Dr. Brett A. Howell Ph.D.
President of Clinical Pharmacology & Pharmacometrics Services
Ms. Jill Fiedler-Kelly M.S.
Show More
Chief Science Officer
Ms. Viera Lukacova Ph.D.
VP of Corporate Counsel & Personal Data Protection Officer
Dr. Bud Nelson J.D., Ph.D.
Corporate Director of Marketing
Ms. Arlene Padron
Executive Director of Human Resources
Ms. Lindsay Luke
Show Less

See Also

Discover More
What is the Intrinsic Value of one SLP stock?

The intrinsic value of one SLP stock under the Base Case scenario is 16.08 USD.

Is SLP stock undervalued or overvalued?

Compared to the current market price of 45.25 USD, Simulations Plus Inc is Overvalued by 64%.